Analystreport

Anthera Pharmaceuticals Inc (NASDAQ: ANTH) had its "buy" rating re-affirmed by analysts at HC Wainwright.

ANTHERA PHARMS INC NEW  (ANTH) 
Last anthera pharms inc new earnings: 11/6 08:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.anthera.com/investor-relations